Chronic Periodontitis

2
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

J&
Johnson & JohnsonNEW BRUNSWICK, NJ
1 program
1
Essential Oils solutionPhase 41 trial
Active Trials
NCT01195493Completed50Est. Jul 2015
Biolase
BiolaseCA - Foothill Ranch
1 program
1
Epic DiodePhase 11 trial
Active Trials
NCT05276817CompletedEst. Dec 2022
Bayer
BayerLEVERKUSEN, Germany
1 program
Dental examination and a point of care P. gingivalis testN/A1 trial
Active Trials
NCT02672384Completed100Est. Oct 2018

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Johnson & JohnsonEssential Oils solution
BiolaseEpic Diode
BayerDental examination and a point of care P. gingivalis test

Clinical Trials (3)

Total enrollment: 150 patients across 3 trials

NCT01195493Johnson & JohnsonEssential Oils solution

Clinical and Microbiological Effects of an Essential Oils Solution Used as an Adjunct to Daily Oral Hygiene Practices in Chronic Periodontitis Patients in Supportive Care

Start: Mar 2010Est. completion: Jul 201550 patients
Phase 4Completed
NCT05276817BiolaseEpic Diode

Perio. Maint. With Diode LBR

Start: Apr 2022Est. completion: Dec 2022
Phase 1Completed
NCT02672384BayerDental examination and a point of care P. gingivalis test

Chronic Periodontitis in Critically Ill Patients: Diagnosis and Epidemiology

Start: Jan 2017Est. completion: Oct 2018100 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 companies competing in this space